Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27237
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSmith, Jennifer L-
dc.contributor.authorSoderstrom, Jessamine-
dc.contributor.authorDawson, Andrew-
dc.contributor.authorAlfred, Sam-
dc.contributor.authorGreene, Shaun L-
dc.contributor.authorIsoardi, Katherine-
dc.contributor.authorMcCutcheon, David-
dc.contributor.authorOosthuizen, Francois-
dc.contributor.authorEzard, Nadine-
dc.contributor.authorBurcham, Jonathon-
dc.contributor.authorFatovich, Daniel M-
dc.date2021-
dc.date.accessioned2021-08-16T05:44:04Z-
dc.date.available2021-08-16T05:44:04Z-
dc.date.issued2022-02-
dc.identifier.citationEmergency medicine Australasia : EMA 2022; 34(1): 58-64en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27237-
dc.description.abstractThe unprecedented rise in synthetic drugs, many containing unknown toxic agents, has made timely analytical diagnosis more difficult, and has reduced the confidence of clinicians providing ED management to this population of patients. This has also impacted the quality of evidence informing harm reduction responses. The Emerging Drugs Network of Australia (EDNA) brings together emergency physicians, toxicologists and forensic laboratories to establish a standardised ED toxicosurveillance system in Australia. Blood analysis of intoxicated patients will be conducted by forensic laboratories to enable precise identification of the substances causing acute toxicity. This will be linked with clinical data collected at the time of ED presentation to enable analysis of the clinical effects and outcomes associated with different illicit and emerging drugs. Toxicological and clinical data collected across sentinel sites will align with a nationally endorsed minimum dataset. EDNA's collaborative network will establish a national system of surveillance and reporting of illicit and emerging drugs causing acute toxicity. Standardisation of data collection recorded in a national clinical registry will provide more robust data on epidemiology and associated harms. This will facilitate the translation of clinical and toxicological evidence into timely, appropriate harm reduction and policy. Our work represents a collaborative response to calls for more sophisticated data on emerging drug trends in Australia. EDNA will improve coordination between clinicians and analytical services by way of its standardised approach to surveillance and reporting.en
dc.language.isoeng-
dc.subjectemergency medicineen
dc.subjectharm reductionen
dc.subjectillicit drug useen
dc.subjectnovel psychoactive substancesen
dc.subjecttoxicologyen
dc.titleThe Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department.en
dc.typeJournal Articleen
dc.identifier.journaltitleEmergency Medicine Australasia : EMAen
dc.identifier.affiliationCentral Clinical School, The University of Sydney, Sydney, New South Wales, Australiaen
dc.identifier.affiliationFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australiaen
dc.identifier.affiliationCentre for Clinical Research in Emergency Medicine, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australiaen
dc.identifier.affiliationEast Metropolitan Health Service, Perth, Western Australia, Australiaen
dc.identifier.affiliationEmergency Department, Royal Perth Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationEmergency Medicine, The University of Western Australia, Perth, Western Australia, Australiaen
dc.identifier.affiliationAlcohol and Drug Service, St Vincent's Hospital, Sydney, New South Wales, Australiaen
dc.identifier.affiliationFaculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australiaen
dc.identifier.affiliationNational Centre for Clinical Research in Emerging Drugs, c/o National Drug and Alcohol Research Centre, The University of New South Wales, Sydney, New South Wales, Australiaen
dc.identifier.affiliationChemCentre WA, Perth, Western Australia, Australiaen
dc.identifier.affiliationNSW Poisons Information Centre, The Children's Hospital at Westmead, Sydney, New South Wales, Australiaen
dc.identifier.affiliationEmergency Department, Royal Adelaide Hospital, Adelaide, South Australia, Australiaen
dc.identifier.affiliationAdelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australiaen
dc.identifier.affiliationEmergencyen
dc.identifier.affiliationVictorian Poisons Information Centreen
dc.identifier.affiliationMelbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationClinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australiaen
dc.identifier.doi10.1111/1742-6723.13839en
dc.type.contentTexten
dc.identifier.orcid0000-0002-0398-2121en
dc.identifier.orcid0000-0002-8047-397Xen
dc.identifier.orcid0000-0002-7423-2467en
dc.identifier.orcid0000-0002-1176-7923en
dc.identifier.orcid0000-0001-8034-7749en
dc.identifier.orcid0000-0002-7495-8305en
dc.identifier.orcid0000-0003-0760-2672en
dc.identifier.orcid0000-0001-9414-6905en
dc.identifier.pubmedid34382338-
local.name.researcherGreene, Shaun L
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEmergency-
crisitem.author.deptToxicology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

86
checked on Jan 13, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.